Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Hendrix

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Medicine|June 3, 2020
Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study among female sex workers in BeninAminata Mboup, Luc Béhanzin, Fernand Guédou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus ProtectionRandy M Stalter, Jared M Baeten, Deborah Donnell, et al.
BMJ Open|July 28, 2019
Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South AfricaLynn T Matthews, Manjeetha Jaggernath, Yolandie Kriel, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxisJafar Sadik Shaik, Ethel D Weld, Stacey Edick, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 27, 2018
Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enemaThuy Hoang, Abhijit A Date, Jairo Ortiz Ortiz, et al.
Plos Medicine|August 24, 2016
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and UgandaJared M Baeten, Renee Heffron, Lara Kidoguchi, et al.
Neuro-Oncology|March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain TumorsStuart A Grossman, Amy Barone, Roy E Strowd, et al.
The Lancet. Infectious Diseases|October 11, 2014
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trialJared M Baeten, Deborah Donnell, Nelly R Mugo, et al.
The Lancet. HIV|October 28, 2023
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Connie Celum, Daniel Szydlo, et al.
The New England Journal of Medicine|July 13, 2012
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenJared M Baeten, Deborah Donnell, Patrick Ndase, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medicine|June 3, 2020
Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study among female sex workers in BeninAminata Mboup, Luc Béhanzin, Fernand Guédou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus ProtectionRandy M Stalter, Jared M Baeten, Deborah Donnell, et al.
BMJ Open|July 28, 2019
Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South AfricaLynn T Matthews, Manjeetha Jaggernath, Yolandie Kriel, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxisJafar Sadik Shaik, Ethel D Weld, Stacey Edick, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 27, 2018
Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enemaThuy Hoang, Abhijit A Date, Jairo Ortiz Ortiz, et al.
Plos Medicine|August 24, 2016
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and UgandaJared M Baeten, Renee Heffron, Lara Kidoguchi, et al.
Neuro-Oncology|March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain TumorsStuart A Grossman, Amy Barone, Roy E Strowd, et al.
The Lancet. Infectious Diseases|October 11, 2014
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trialJared M Baeten, Deborah Donnell, Nelly R Mugo, et al.
The Lancet. HIV|October 28, 2023
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Connie Celum, Daniel Szydlo, et al.
The New England Journal of Medicine|July 13, 2012
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenJared M Baeten, Deborah Donnell, Patrick Ndase, et al.
Pageof 4